Atlas Trials

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults

Clinical trial NCT03430349 · COMPLETED

Trial details

NCT number
NCT03430349
Sponsor
Pierre Van Damme
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Poliomyelitis
Start date
2017-05-16
Primary completion
2017-09-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.